Jubilant Pharmova has announced that Jubilant Pharma, a material wholly-owned subsidiary of the company, through one of its subsidiaries, Jubilant Cadista Pharmaceuticals has received Abbreviated New Drug Application (ANDA) final approval for Doxepin Hydrochloride Capsules, 10 mg, 25mg, 50mg, 75mg, and 100mg, the generic version of Sinequan, which is used for the treatment of anxiety, depression, and other target symptoms of psychoneurosis.